AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.

52W High

$9.79

52W Low

$6.68

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.19

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

962.00

Forward P/E (<15 better)

6.30

EV/EBITDA (<8 favorable)

9.47

EV/Revenue (<3 favorable)

1.94

P/S (TTM) (<3 favorable)

1.06

P/B (<3 favorable)

86.10

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

46.49%

Institutions (25–75% balanced)

45.92%

Shares Outstanding

314,079,000

Float

168,758,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,852,914,000

Gross Profit (TTM)

1,067,892,000

EPS (TTM)

0.01

Profit Margin (>10% good)

0.00%

Operating Margin (TTM) (higher better)

0.16%

ROE (TTM) (>15% strong)

-8.81%

EPS YoY (Quarterly) (>10% good)

2.61

Revenue YoY (Quarterly) (>8% good)

0.03

Momentum

Bearish momentum

Value

0.3815

0.3794

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025